SHPG Share Price

Open 174.50 Change Price %
High 175.50 1 Day 3.82 2.23
Low 173.05 1 Week -0.43 -0.25
Close 174.80 1 Month 8.42 5.06
Volume 971939 1 Year -28.81 -14.15
52 Week High 210.33
52 Week Low 147.60
SHPG Important Levels
Resistance 2 177.07
Resistance 1 176.14
Pivot 174.45
Support 1 173.46
Support 2 172.53
NASDAQ USA Most Active Stocks
SIRI 4.30 -5.49%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
QQQ 115.67 0.17%
WRES 0.09 0.00%
More..
NASDAQ USA Top Gainers Stocks
QKLS 0.21 110.00%
LOCM 0.09 50.00%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
PERF 1.90 22.58%
ASNA 7.01 20.24%
SBSA 4.60 17.95%
CEMP 7.55 15.27%
XXIA 15.55 14.76%
More..
NASDAQ USA Top Losers Stocks
PTIX 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.03 -50.00%
OPXAW 0.01 -50.00%
VALV 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
More..

Shire plc (NASDAQ: SHPG)

SHPG Technical Analysis 3
As on 2nd Dec 2016 SHPG Share Price closed @ 174.80 and we RECOMMEND Sell for LONG-TERM with Stoploss of 181.29 & Sell for SHORT-TERM with Stoploss of 184.97 we also expect STOCK to react on Following IMPORTANT LEVELS.
SHPG Target for December
1st Target up-side 191.58
2nd Target up-side 203.46
3rd Target up-side 215.34
1st Target down-side 157.7
2nd Target down-side 145.82
3rd Target down-side 133.94
Shire plc ( NASDAQ USA Symbol : SHPG )
Sector : N/AIndustry:N/AFull Time Employees:5,338Business Summary Shire plc, a biopharmaceutical company, together with its subsidiaries, researches, develops, licenses, manufactures, markets, distributes, and sells pharmaceutical products. It offers various And Other Stocks in Same Sector
SHPG
174.80 3.82 (2.23 %)
LT : Sell
ST : Sell
SHPG Other Details
Segment EQ
Market Capital 16032273408.00
Sector N/AIndustry:N/AFull Time Employees:5,338Business Summary Shire plc, a biopharmaceutical company, together with its subsidiaries, researches, develops, licenses, manufactures, markets, distributes, and sells pharmaceutical products. It offers various
Industry N/AFull Time Employees:5,338Business Summary Shire plc, a biopharmaceutical company, together w
Offical website http://www.shire.com
SHPG Address
SHPG
5 Riverwalk
Citywest Business Campus
Dublin, 24
Ireland
Phone: 353 1 429 7700
Interactive Technical Analysis Chart Shire plc ( SHPG NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Shire plc
SHPG Business Profile
Shire plc (Shire) is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), gastrointestinal (GI) diseases, human genetic therapies (HGT) and regenerative medicine (RM), as well as opportunities in other therapeutic areas. On January 31, 2012, the United States Food and Drug Administration approved VYVANSE for the maintenance treatment of ADHD in adults. In March 2013, it announced the acquisition Of Premacure AB. In January 2014, Shire Plc sold its DERMAGRAFT assets to Organogenesis Inc. In January 2014, Shire Plc acquired 79.5% interest in ViroPharma Inc.